John Bush Idoko | Cardiology | Research Excellence Award

Health Scientists Awards

John Bush Idoko
Near East University, Cyprus

John Bush Idoko
Affiliation Near East University
Country Cyprus
Scopus ID 57200209705
Documents 55
Citations 481
h-index 10
Subject Area Cardiology
Event Health Scientists Awards

John Bush Idoko is a researcher affiliated with Near East University in Cyprus whose scholarly activities span medical and health sciences with notable engagement in cardiology-related research and interdisciplinary biomedical investigations. His publication portfolio demonstrates contributions to machine learning applications in health sciences, neurological signal processing, and clinical analytics. The researcher has established measurable academic visibility through indexed publications, citations, and collaborative scientific output documented in major international databases.[1]

Abstract

This academic article presents a structured overview of the scholarly profile and research contributions of John Bush Idoko of Near East University, Cyprus. The page evaluates the researcher’s publication activities, citation indicators, interdisciplinary collaborations, and contributions to health science and biomedical analytics. Particular attention is given to publications associated with neurological diagnostics, deep learning applications in medicine, and computational approaches to health-related signal analysis. The article further discusses the relevance of the researcher’s scientific portfolio within the context of the Health Scientists Awards and highlights the consistency of publication productivity and research visibility within indexed academic databases.[2]

Keywords

Cardiology, Biomedical Engineering, Machine Learning, EEG Analysis, Deep Learning, Health Sciences, Clinical Analytics, Medical Informatics, Computational Medicine, Scientific Impact

Introduction

Contemporary health sciences increasingly integrate computational technologies, biomedical analytics, and artificial intelligence methodologies to improve diagnostic accuracy and healthcare efficiency. Researchers working at the intersection of medical sciences and intelligent systems contribute significantly to the modernization of healthcare research infrastructure. John Bush Idoko’s scholarly activities align with these evolving academic trends through publications associated with neural network methodologies, biomedical signal processing, and clinical interpretation systems.[3]

The international research environment has increasingly recognized interdisciplinary scientific collaborations that combine computational modeling with clinical sciences. Academic researchers contributing to this area frequently engage in studies involving diagnostic systems, machine learning algorithms, and predictive analytics for medical applications. Publications attributed to John Bush Idoko indicate participation in these developing scientific domains with measurable scholarly visibility across indexed academic platforms.[1]

Research Profile

John Bush Idoko is affiliated with Near East University in Cyprus and has developed an academic profile characterized by interdisciplinary research contributions involving medical sciences, signal processing, and intelligent computational systems. According to indexed bibliographic records, the researcher has produced 55 documents with 481 citations and an h-index of 10, reflecting moderate and consistent scholarly engagement within internationally indexed literature.[1]

The researcher’s publication trajectory demonstrates collaborative engagement with scientists from multiple institutions and disciplinary backgrounds. Several studies involve neural networks, convolutional deep learning systems, biomedical image interpretation, and clinical decision-support methodologies. Such interdisciplinary research profiles are increasingly important in modern health science ecosystems where computational methods assist in healthcare diagnostics and patient management strategies.[4]

Research Contributions

The research contributions associated with John Bush Idoko include investigations into biomedical signal analysis, epileptic EEG identification systems, and deep learning approaches for medical pattern recognition. These contributions reflect ongoing scientific interest in leveraging computational intelligence to improve diagnostic precision and clinical interpretation methodologies.[2]

One area of scholarly contribution involves convolutional neural network applications for EEG signal classification. Research in this area supports the development of automated neurological analysis systems capable of assisting healthcare practitioners in diagnostic processes. Such studies contribute to broader efforts within biomedical engineering and clinical informatics aimed at improving healthcare efficiency and analytical reliability.[3]

Additional contributions include studies related to sign language translation using deep neural networks and interdisciplinary artificial intelligence frameworks applied to health communication technologies. These works collectively illustrate the researcher’s participation in computational approaches that support healthcare accessibility, diagnostic automation, and biomedical data interpretation.[4]

Publications

  • Abiyev, R., Arslan, M., Idoko, J. B., Sekeroglu, B., & Ilhan, A. “Identification of epileptic EEG signals using convolutional neural networks.” Applied Sciences, 2020.
    https://doi.org/10.3390/app10124089
  • Abiyev, R. H., Arslan, M., & Idoko, J. B. “Sign language translation using deep convolutional neural networks.” KSII Transactions on Internet and Information Systems, 2020.
    https://doi.org/10.3837/tiis.2020.02.018
  • Research publications involving biomedical data analytics, machine learning applications, and intelligent healthcare systems indexed within Scopus and Google Scholar databases.[1]

Research Impact

The measurable research impact associated with John Bush Idoko is reflected through citation activity, interdisciplinary collaborations, and publication visibility across recognized indexing platforms. Citation metrics indicate that the researcher’s publications have contributed to ongoing academic discussions within biomedical engineering, computational medicine, and health informatics.[1]

The integration of deep learning methodologies into biomedical diagnostics represents an active area of international scientific development. Contributions related to EEG analysis and medical classification systems have relevance to modern healthcare technologies and emerging intelligent diagnostic infrastructures. Such research may contribute to future clinical applications, data interpretation systems, and computational healthcare solutions.[2]

Award Suitability

The scholarly profile of John Bush Idoko demonstrates characteristics commonly associated with academic recognition programs in health sciences, including interdisciplinary collaboration, indexed publication output, citation visibility, and engagement with emerging biomedical technologies. The integration of artificial intelligence methodologies into health science investigations aligns with evolving priorities within international healthcare research communities.[4]

The Health Scientists Awards program recognizes researchers whose academic contributions support innovation, scientific advancement, and interdisciplinary development in healthcare-related fields. Based on available bibliographic indicators and publication themes, the researcher’s profile demonstrates relevance to these academic evaluation criteria.[5]

Conclusion

John Bush Idoko’s academic profile reflects ongoing contributions to interdisciplinary health science research involving machine learning, biomedical analytics, and intelligent diagnostic systems. Indexed publications, citation metrics, and collaborative research activities collectively indicate sustained engagement with contemporary computational healthcare methodologies. The researcher’s portfolio demonstrates relevance within emerging scientific areas that integrate biomedical sciences and artificial intelligence technologies. Such contributions support broader international efforts aimed at improving healthcare diagnostics, analytical efficiency, and digital health innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: John Bush Idoko, Author ID 57200209705. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57200209705
  2. Abiyev, R., Arslan, M., Idoko, J. B., Sekeroglu, B., & Ilhan, A. (2020). Identification of epileptic EEG signals using convolutional neural networks. Applied Sciences.
    https://doi.org/10.3390/app10124089
  3. Google Scholar. (n.d.). John Bush Idoko citation profile and indexed publications.
    https://scholar.google.com/citations?user=eVqc6HkAAAAJ&hl=en&oi=ao
  4. Sekeroglu, B., Abiyev, R., Ilhan, A., Arslan, M., & Idoko, J. B. “Systematic literature review on machine learning and student performance prediction: Critical gaps and possible remedies.” Applied Sciences, 11(22), 10907. https://doi.org/10.3390/app112210907
  5. Health Scientists Awards. (n.d.). Official award information and evaluation categories.
    https://healthscientists.org/

Na Wu | Biosensor Early Diagnosis | Best Research Article Award

Dr. Na Wu | Biosensor Early Diagnosis | Best Research Article Award

Assistant Researcher at Fujian Medical University, China

Dr. Na Wu is a promising researcher in the field of bioanalytical chemistry, with a strong focus on molecular diagnostics and nucleic acid-based detection systems. Her recent publication in Talanta (2026), exploring high-affinity poly-cytosine DNA modulated metal-organic frameworks for hepatocellular carcinoma detection, exemplifies her innovative approach. She has published extensively in prestigious journals such as ACS Nano, Analytical Chemistry, and Small, often as a lead or corresponding author. Her research combines nanotechnology, machine learning, and DNA nanodevices to develop ultrasensitive, non-invasive diagnostic tools for early cancer detection. With international academic training and a leadership role in a major research project at Fujian Medical University, Dr. Wu demonstrates both technical excellence and research initiative. While increased emphasis on clinical translation and broader recognition metrics could enhance her profile further, her current contributions position her as a strong candidate for the Best Research Article Award, with impactful and forward-thinking scientific work.

Professional Profile

Education🎓

Dr. Na Wu has a strong academic foundation in chemistry, beginning with her Bachelor’s degree in Applied Chemistry from Zhoukou Normal University (ZKNU), China, in 2017. She continued her academic journey by pursuing a Doctorate in Chemistry at Northeastern University (NEU), Shenyang, where she worked under the guidance of Prof. Ting Yang. To enhance her research skills and international experience, Dr. Wu undertook a joint doctoral training program at the University of Waterloo (UW), Canada, from March 2022 to September 2023, under the mentorship of Prof. Juewen Liu, a renowned expert in nanotechnology and biosensing. This international exposure significantly enriched her expertise in advanced analytical techniques, DNA nanotechnology, and biomedical applications. Her academic training across these prestigious institutions has equipped her with a solid interdisciplinary background, blending theoretical knowledge with hands-on research experience. This educational trajectory has laid the groundwork for her innovative contributions to molecular diagnostics and bioanalytical chemistry.

Professional Experience📝

Dr. Na Wu has built a promising professional career grounded in both academic teaching and advanced research. She began her professional journey in March 2024 as a Lecturer at Fujian Medical University (FJMU), where she is actively involved in teaching and leading innovative research projects in molecular diagnostics. Concurrently, she is engaged in a post-doctoral position at Fuzhou University (FZU), set to run from March 2025 to March 2027, allowing her to further deepen her expertise in biomedical applications and collaborative scientific inquiry. Dr. Wu also leads a major research initiative funded by Fujian Medical University, focusing on high-level talent development in nucleic acid delivery systems and liquid biopsy technologies. Her dual roles highlight a balance of academic instruction and high-impact research leadership. Through these positions, she contributes significantly to the fields of analytical chemistry and biosensor development, demonstrating both scientific excellence and commitment to advancing healthcare-related research.

Research Interest🔎

Dr. Na Wu’s research interests lie at the intersection of analytical chemistry, molecular diagnostics, and nanobiotechnology, with a particular focus on the development of innovative nucleic acid-based detection systems. She is dedicated to designing advanced biosensors and DNA nanodevices for the early diagnosis of cancers and infectious diseases. Her work emphasizes the use of three-dimensional DNA machines, metal-organic frameworks, and machine learning-assisted platforms to enable ultrasensitive, specific, and non-invasive diagnostic tools. Dr. Wu is also deeply engaged in liquid biopsy research, exploring biomarkers such as circulating DNA and D-amino acids for clinical applications. Additionally, she investigates nucleic acid delivery systems that enhance the precision and efficiency of molecular diagnostics. Her interdisciplinary approach bridges chemistry, biology, and data science, aiming to translate laboratory innovations into real-world healthcare solutions. Through her research, Dr. Wu seeks to address pressing medical challenges by advancing the next generation of rapid and reliable diagnostic technologies.

Award and Honor🏆

Dr. Na Wu has earned recognition for her contributions to the field of analytical chemistry and molecular diagnostics through prestigious research roles and funding support. She was awarded the Fujian Medical University High-Level Talent Research Startup Funding Project, which she leads, reflecting her potential as an emerging leader in scientific innovation. This competitive grant supports her ongoing work in developing advanced nucleic acid-based biosensors for early disease detection. Her selection for a joint doctoral training program at the University of Waterloo, Canada, is another significant academic honor, highlighting her international research capabilities and collaboration with globally recognized experts. Additionally, her publications in high-impact journals such as Analytical Chemistry, ACS Nano, and Talanta further affirm the scientific community’s acknowledgment of her research excellence. These accomplishments demonstrate Dr. Wu’s commitment to advancing healthcare diagnostics and position her as a rising scholar with a growing influence in the fields of nanobiotechnology and molecular sensing.

Research Skill🔬

Dr. Na Wu possesses a diverse and advanced set of research skills that span analytical chemistry, molecular biology, and nanotechnology. She is highly proficient in designing and fabricating DNA-based biosensors, including three-dimensional DNA machines and nucleic acid delivery systems, for ultra-sensitive disease diagnostics. Her technical expertise includes synthesis and modification of nanomaterials, molecular recognition techniques, signal amplification strategies, and integration of machine learning algorithms for enhanced data analysis and diagnostic accuracy. Dr. Wu is skilled in employing liquid biopsy approaches to detect cancer biomarkers and has experience with techniques such as electrochemiluminescence, fluorescence spectroscopy, and metal-organic frameworks for biomolecular interactions. Her strong background in interdisciplinary research enables her to bridge gaps between chemistry, biology, and clinical applications. Additionally, she demonstrates competence in scientific writing, project management, and international collaboration, having worked in top-tier labs in both China and Canada. These research skills collectively underpin her ability to lead innovative and impactful scientific projects.

Conclusion💡

Dr. Na Wu is a strong and deserving candidate for the Best Research Article Award, particularly for her recent paper in Talanta (2026) on the detection of hepatocellular carcinoma biomarkers using poly-cytosine DNA and metal-organic frameworks. Her research demonstrates originality, scientific rigor, and relevance to modern health diagnostics. With a growing publication record and leadership in funded research, she represents the next generation of innovators in bioanalytical chemistry. Strengthening her clinical collaborations and visibility in global research communities will further elevate her candidacy in future evaluations.

Publications Top Noted✍

  1. Title: High-affinity poly-cytosine DNA modulated metal-organic framework-DNA interactions and their application in detection of hepatocellular carcinoma biomarker
    Authors: Wu, N.; Chen, X.; Wang, Y.-T.; Jiang, Y.; Gao, Z.
    Year: 2026
    Citations: [Citation data not available yet – newly published]

  2. Title: Hydrogen peroxide regulated split-type electrochemiluminescence sensing platform for non-invasive detection of gastric cancer-associated D-amino acids
    Authors: Li, J.; Lai, M.-C.; Zhong, Y.-M.; Chen, Y.-L.; Wu, N.; Chen, W.; Peng, H.-P.
    Year: 2025
    Citations: [Citation data pending]

  3. Title: An extracellular vesicle microRNA-initiated 3D DNAzyme motor for colorectal cancer diagnosis
    Authors: Fan, Q.; Sun, X.-H.; Wu, N.; Wang, Y.-H.; Wang, J.-H.; Yang, T.
    Year: 2024
    Citations: [Check citation databases]

  4. Title: Multispectral 3D DNA Machine Combined with Multimodal Machine Learning for Noninvasive Precise Diagnosis of Bladder Cancer
    Authors: Wu, N.; Wong, K.-Y.; Yu, X.; Zhao, J.-W.; Zhang, X.-Y.; Wang, J.-H.; Yang, T.
    Year: 2024
    Citations: [Available on Scopus/Google Scholar]

  5. Title: Demoralization, apathy, and depression affect cognition and motor symptoms in Parkinson’s disease
    Authors: Zhu, X.; Gan, J.; Wu, N.; Zhang, Y.; Liu, Z.
    Year: 2024
    Citations: [Check Web of Science/Scopus]

  6. Title: Cytosine-Rich DNA Binding Insulin Stronger than Guanine-Rich Aptamers
    Authors: Wu, N.; Zandieh, M.; Yang, T.; Liu, J.
    Year: 2023
    Citations: [Check Scopus]

  7. Title: DNA-functionalized LnNP-MNP assemblies for dual-mode sensing of alkaline phosphatase
    Authors: Sun, X.-Y.; Wei, X.; Wu, N.; Liu, X.; Chen, M.-L.; Wang, J.-H.
    Year: 2023
    Citations: [Check Scopus]

  8. Title: Detection of HIV/HCV virus DNA with homogeneous DNA machine-triggered in situ formation of silver nanoclusters
    Authors: Wu, N.; Zhang, H.-C.; Sun, X.-H.; Guo, F.-N.; Feng, L.-X.; Yang, T.; Wang, J.-H.
    Year: 2022
    Citations: [Scopus indexed]

  9. Title: Immunolabeling lanthanide nanoparticles for alpha-fetoprotein detection using ICP-MS
    Authors: Sun, X.; Wei, X.; Liu, X.; Zhang, X.; Wu, N.; Liu, J.; Wang, Y.; Chen, M.; Wang, J.
    Year: 2022
    Citations: [Check databases]

  10. Title: Efficient Pathogen Capture and Sensing Promoted by Dynamic Deformable Nanointerfaces
    Authors: Cao, Y.; Wu, N.; Li, H.-D.; Xue, J.-W.; Wang, R.; Yang, T.; Wang, J.-H.
    Year: 2022
    Citations: [Published in Small – high impact]

  11. Title: Ratiometric 3D DNA Machine Combined with Machine Learning Algorithm for Early Urinary Disease Screening
    Authors: Wu, N.; Zhang, X.-Y.; Xia, J.; Li, X.; Yang, T.; Wang, J.-H.
    Year: 2021
    Citations: [Likely cited – check ACS Nano]

  12. Title: Three-Dimensional DNA Nanomachine Biosensor for Cancer-Related Gene Detection
    Authors: Wu, N.; Wang, Y.-T.; Chang, M.-L.; Chen, X.-W.; Yang, T.; Wang, J.-H.
    Year: 2020
    Citations: [Check citation database